These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


199 related items for PubMed ID: 12667394

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Hybrid cells formed by fusion of Epstein-Barr virus-associated B-lymphoblastoid cells and either marrow-derived or solid tumour-derived cell lines display different co-stimulatory phenotypes and abilities to activate allogeneic T-cell responses in vitro.
    Cywinski AL, Dunnion DJ, Teobald I, Tucker VC, Browning MJ.
    Tissue Antigens; 2006 Aug; 68(2):115-26. PubMed ID: 16866881
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Lack of CD80 expression by fibroblast-like synoviocytes leading to anergy in T lymphocytes.
    Corrigall VM, Solau-Gervais E, Panayi GS.
    Arthritis Rheum; 2000 Jul; 43(7):1606-15. PubMed ID: 10902766
    [Abstract] [Full Text] [Related]

  • 27. B7.1 immunogene therapy effectively activates CD(4+) tumor-infiltrating lymphocytes in the central nervous system in comparison with B7.2 gene therapy.
    Ando H, Saio M, Ohe N, Tamakawa N, Yu H, Nakayama T, Yoshimura S, Kaku Y, Iwama T, Shinoda J, Sakai N, Takami T.
    Int J Oncol; 2002 Apr; 20(4):807-12. PubMed ID: 11894129
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Expression of functional B7-H2 and B7.2 costimulatory molecules and their prognostic implications in de novo acute myeloid leukemia.
    Tamura H, Dan K, Tamada K, Nakamura K, Shioi Y, Hyodo H, Wang SD, Dong H, Chen L, Ogata K.
    Clin Cancer Res; 2005 Aug 15; 11(16):5708-17. PubMed ID: 16115907
    [Abstract] [Full Text] [Related]

  • 30. B7/BB-1 is a leucocyte differentiation antigen on human dendritic cells induced by activation.
    Hart DN, Starling GC, Calder VL, Fernando NS.
    Immunology; 1993 Aug 15; 79(4):616-20. PubMed ID: 8406586
    [Abstract] [Full Text] [Related]

  • 31. Expression of the B7-related molecule B7-H1 by glioma cells: a potential mechanism of immune paralysis.
    Wintterle S, Schreiner B, Mitsdoerffer M, Schneider D, Chen L, Meyermann R, Weller M, Wiendl H.
    Cancer Res; 2003 Nov 01; 63(21):7462-7. PubMed ID: 14612546
    [Abstract] [Full Text] [Related]

  • 32. A novel bispecific tetravalent antibody fusion protein to target costimulatory activity for T-cell activation to tumor cells overexpressing ErbB2/HER2.
    Biburger M, Weth R, Wels WS.
    J Mol Biol; 2005 Mar 11; 346(5):1299-311. PubMed ID: 15713482
    [Abstract] [Full Text] [Related]

  • 33. Expression of costimulatory molecules on human retinoblastoma cells Y-79: functional expression of CD40 and B7H1.
    Usui Y, Okunuki Y, Hattori T, Takeuchi M, Kezuka T, Goto H, Usui M.
    Invest Ophthalmol Vis Sci; 2006 Oct 11; 47(10):4607-13. PubMed ID: 17003458
    [Abstract] [Full Text] [Related]

  • 34. Newcastle disease virus infection induces B7-1/B7-2-independent T-cell costimulatory activity in human melanoma cells.
    Termeer CC, Schirrmacher V, Bröcker EB, Becker JC.
    Cancer Gene Ther; 2000 Feb 11; 7(2):316-23. PubMed ID: 10770642
    [Abstract] [Full Text] [Related]

  • 35. CD 80(B7-1) expression on human tumor cell lines and its costimulatory signals for T cell proliferation and cytokine production.
    Yan J, Ma B, Guo X, Sun Y, Zhang J, Zhang H.
    Chin Med J (Engl); 1998 Mar 11; 111(3):269-71. PubMed ID: 10374432
    [Abstract] [Full Text] [Related]

  • 36. B7-1/B7-2 costimulation regulates plaque antigen-specific T-cell responses and atherogenesis in low-density lipoprotein receptor-deficient mice.
    Buono C, Pang H, Uchida Y, Libby P, Sharpe AH, Lichtman AH.
    Circulation; 2004 Apr 27; 109(16):2009-15. PubMed ID: 15096453
    [Abstract] [Full Text] [Related]

  • 37. Renal tubular epithelial expression of the coinhibitory molecule B7-DC (programmed death-1 ligand).
    Zhang J, Chen Y, Li J, Zhang R, Wu Y, Zou L, Zhao T, Zhang X, Han J, Chen A, Wu Y.
    J Nephrol; 2006 Apr 27; 19(4):429-38. PubMed ID: 17048200
    [Abstract] [Full Text] [Related]

  • 38. B7.2-Ig fusion proteins enhance IL-4-dependent differentiation of tumor-sensitized CD8+ cytotoxic T lymphocyte precursors.
    Hiraoka S, Takeuchi N, Bian Y, Nakahara H, Kogo M, Dunussi-Joannopoulos K, Wolf S, Ono S, Fujiwara H.
    Int Immunol; 2005 Aug 27; 17(8):1071-9. PubMed ID: 16027141
    [Abstract] [Full Text] [Related]

  • 39. Triptolide inhibits B7-H1 expression on proinflammatory factor activated renal tubular epithelial cells by decreasing NF-kappaB transcription.
    Chen Y, Zhang J, Li J, Zhao T, Zou L, Tang Y, Zhang X, Wu Y.
    Mol Immunol; 2006 Mar 27; 43(8):1088-98. PubMed ID: 16129490
    [Abstract] [Full Text] [Related]

  • 40. A rapid, novel strategy to induce tumor cell-specific cytotoxic T lymphocyte responses using instant dentritomas.
    Holmes LM, Li J, Sticca RP, Wagner TE, Wei Y.
    J Immunother; 2001 Mar 27; 24(2):122-9. PubMed ID: 11265769
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.